Similarly, WGS of ~1,000 clonal haematopoietic colonies from patients with myeloproliferative neoplasms demonstrated that the acquisition of JAK2‐V617F driver mutations often occurred early in life, including during the in utero period [99]. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.